Fig 4. Performance of bispecific Abs and 2 Ab combinations involving bispecifics.

(A-C) same as Fig 3A–3C, respectively, except combinations of both bispecific Abs and of the type bispecific + conventional Abs are considered. For combinations of 3BNC117-PGT135 bispecific with bnAbs, only V2 glycan bnAbs are considered to ensure non-overlapping epitope regions with the bispecific.